Die Inhalte dieser Veranstaltung werden produkt- und dienstleistungsneutral gestaltet. Wir bestätigen, dass die wissenschaftliche Leitung und die Referenten potentielle Interessenskonflikte gegenüber den Teilnehmern offenlegen.
Offenlegung von Interessenskonflikten für Prof. Dr. Heinz Wiendl der letzten 12 Monaten (Stand 25.07.2024):
Honorar für Vortrags- und/oder Beratertätigkeiten: Alexion, Argenx, Argobio, AstraZeneca, Biocryst, Biogen, BGP Products Operations GmbH, Bristol Myers Squibb, Cellerys, CEMCAT, EMD Serono, EPG Health/Medthority, Fondazione Cariplo, Galapagos, Genzyme, Idorsia, Immunic, Immunovant, Inmune Bio Syneos Health Janssen, LTS, Lundbeck, Kohlhammer, Merck, Muna Therapeutics, Myrobalan Therapeutics, Neurodiem, Novartis, Ology, PSL, Red Nucleus, Roche, Samsung, Sangamo, Sandoz-Hexal, Sanofi, Springer, Streamed up, Swiss Multiple Sclerosis Society, Teladochealth, TEVA, Toleranzia, UCB, Uvet, uniQure biopharma B.V., Viatris, WebMD Global.
Übernachtungs- und Reisekosten: Alexion, AOCN, CEMCAT, AstraZeneca, Biogen, Bristol Myers Squibb, Genzyme, Merck, MS at the Limits, Neurodiem, NMSS, Novartis, Roche, Sanofi, Streamed up,TEVA, Uvet, WebMD Global.
Forschungs- und Studiengelder: Deutsche Forschungsgemeinschaft (DFG), Deutsche Myasthenie Gesellschaft e.V., European Union, Alexion, Amicus Therapeutics Inc., Argenx, Biogen, CSL Behring, F. Hoffmann - La Roche, Genzyme, Merck KgaA, Novartis, Roche, UCB Biopharma.
The content of this event is designed to be product- and service-neutral. We confirm that the scientific management and speakers disclose any potential conflicts of interest to participants.
Disclorure conflict of interest forProf. Dr. Heinz Wiendl der letzten 12 Monaten (Stand 25.07.2024)
:
Fees for lectures and/or consulting services: Alexion, Argenx, Argobio, AstraZeneca, Biocryst, Biogen, BGP Products Operations GmbH, Bristol Myers Squibb, Cellerys, CEMCAT, EMD Serono, EPG Health/Medthority, Fondazione Cariplo, Galapagos, Genzyme, Idorsia, Immunic, Immunovant, Inmune Bio Syneos Health Janssen, LTS, Lundbeck, Kohlhammer, Merck, Muna Therapeutics, Myrobalan Therapeutics, Neurodiem, Novartis, Ology, PSL, Red Nucleus, Roche, Samsung, Sangamo, Sandoz-Hexal, Sanofi, Springer, Streamed up, Swiss Multiple Sclerosis Society, Teladochealth, TEVA, Toleranzia, UCB, Uvet, uniQure biopharma B.V., Viatris, WebMD Global.
Accommodation and travel expenses: Alexion, AOCN, CEMCAT, AstraZeneca, Biogen, Bristol Myers Squibb, Genzyme, Merck, MS at the Limits, Neurodiem, NMSS, Novartis, Roche, Sanofi, Streamed up,TEVA, Uvet, WebMD Global.
Research and study grants: Deutsche Forschungsgemeinschaft (DFG), Deutsche Myasthenie Gesellschaft e.V., European Union, Alexion, Amicus Therapeutics Inc., Argenx, Biogen, CSL Behring, F. Hoffmann - La Roche, Genzyme, Merck KgaA, Novartis, Roche, UCB Biopharma.
